Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. DVAX.NASDAQ

Dynavax Technologies Corporation (DVAX NASDAQ) stock market data APIs

$11.6 -0.01(-0.1%) as of July 26, 2024
Price chart is built with Anychart

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.

Dynavax Technologies Corporation Financial Data Overview

11.61
11.6
-
11.7
11.5
10.23-15.15
1 503 M
164
131 M
236 M
-0.07
1.276
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'DVAX',
Type: 'Common Stock',
Name: 'Dynavax Technologies Corporation',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000BFX694',
ISIN: NULL,
CUSIP: NULL,
CIK: '1029142',
EmployerIdNumber: '33-0728374',
FiscalYearEnd: 'December',
IPODate: '2004-02-19',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Dynavax Technologies Corporation Fundamental Data is available in our Financial Data APIs

  • Net Revenue 236 M
  • EBITDA -16 719 000
  • Earnings Per Share 0.07
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Dynavax Technologies Corporation Earnings via APIs

  • Latest Release 2024-05-08
  • EPS/Forecast -0.02

Get Dynavax Technologies Corporation End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Dynavax Technologies Corporation latest news via APIs

Dynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024

EMERYVILLE, Calif., July 23, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will...

Dynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program

EMERYVILLE, Calif., June 27, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, toda...
Do you have any questions?
support@eodhistoricaldata.com